French drug major Sanofi (SNY) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy ...
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of ...
The FDA bestows a Breakthrough Therapy designation to Sanofi's tolebrutinib for treating non-relapsing secondary progressive multiple sclerosis.
Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosisDesignation is based on ...
Berger specialized in cancer long before joining Genentech, holding oncology global clinical development roles at Amgen and ...
The FDA has granted Breakthrough Therapy designation to tolebrutinib for treating adults with non-relapsing secondary ...
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS).
The Breakthrough Therapy designation is supported by data from the randomized, double-blind phase 3 HERCULES trial.
Satellite images reveal Russian military equipment being prepared for loading, a possible prelude to its withdrawal from Syria. Travis Timmerman, an American who was found earlier this week, was ...
Lyon have made a last-ditch attempt to lure England and Lions hooker Luke Cowan-Dickie away from Sale Sharks just over a week afte… The 31-year-old is one of eight members of this year’s Rugby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback